FMR LLC - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 149 filers reported holding AMICUS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.

Quarter-by-quarter ownership
FMR LLC ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,783,300
+16.5%
2,778,232
+20.3%
0.00%
+50.0%
Q2 2023$29,008,838
-40.7%
2,309,621
-47.7%
0.00%0.0%
Q1 2023$48,956,538
+60.9%
4,414,476
+77.2%
0.00%
-33.3%
Q4 2022$30,423,022
+4.3%
2,491,648
-10.8%
0.00%0.0%
Q3 2022$29,170,000
+32.5%
2,794,068
+36.3%
0.00%
+50.0%
Q2 2022$22,013,000
+35.8%
2,049,617
+19.8%
0.00%
+100.0%
Q1 2022$16,204,000
-12.3%
1,711,089
+7.0%
0.00%0.0%
Q4 2021$18,478,000
+48.4%
1,599,832
+22.7%
0.00%0.0%
Q3 2021$12,454,000
-0.9%
1,304,1320.0%0.00%0.0%
Q2 2021$12,572,000
+129.0%
1,304,132
+134.6%
0.00%
Q1 2021$5,491,000
-93.6%
555,812
-85.0%
0.00%
-100.0%
Q4 2020$85,525,000
+37.9%
3,703,955
-15.7%
0.01%
+33.3%
Q3 2020$62,031,000
-48.2%
4,393,188
-44.7%
0.01%
-53.8%
Q2 2020$119,860,000
+60.8%
7,948,271
-1.5%
0.01%
+30.0%
Q1 2020$74,546,000
+318.8%
8,067,808
+341.4%
0.01%
+400.0%
Q4 2019$17,802,000
-20.9%
1,827,687
-34.9%
0.00%
-33.3%
Q3 2019$22,505,000
-74.1%
2,806,034
-59.7%
0.00%
-70.0%
Q2 2019$86,932,000
-57.9%
6,965,715
-54.1%
0.01%
-60.0%
Q1 2019$206,446,000
+20.1%
15,179,860
-15.4%
0.02%
+4.2%
Q4 2018$171,900,000
+5.6%
17,943,523
+33.3%
0.02%
+33.3%
Q3 2018$162,777,000
-22.7%
13,463,780
-0.1%
0.02%
-25.0%
Q2 2018$210,468,000
+3.8%
13,474,295
-0.0%
0.02%0.0%
Q1 2018$202,715,000
-21.7%
13,478,355
-25.1%
0.02%
-20.0%
Q4 2017$258,782,000
-11.2%
17,983,531
-6.9%
0.03%
-14.3%
Q3 2017$291,283,000
+34.9%
19,315,817
-9.9%
0.04%
+29.6%
Q2 2017$215,876,000
+46.0%
21,437,508
+3.4%
0.03%
+42.1%
Q1 2017$147,822,000
+39.3%
20,732,355
-2.9%
0.02%
+35.7%
Q4 2016$106,103,000
-32.8%
21,348,929
+0.1%
0.01%
-33.3%
Q3 2016$157,774,000
+51.9%
21,320,863
+12.1%
0.02%
+50.0%
Q2 2016$103,865,000
-34.4%
19,023,053
+1.6%
0.01%
-36.4%
Q1 2016$158,211,000
-12.9%
18,723,103
-0.1%
0.02%
-8.3%
Q4 2015$181,729,000
-12.2%
18,734,915
+26.6%
0.02%
-17.2%
Q3 2015$206,982,000
+11.7%
14,794,969
+12.9%
0.03%
+20.8%
Q2 2015$185,370,000
+2930.4%
13,100,348
+2230.2%
0.02%
+2300.0%
Q1 2015$6,117,000
+30.8%
562,2040.0%0.00%0.0%
Q4 2014$4,678,000
+39.9%
562,2040.0%0.00%
Q3 2014$3,345,000
+78.1%
562,2040.0%0.00%
Q2 2014$1,878,000
+61.3%
562,2040.0%0.00%
Q1 2014$1,164,000
-11.9%
562,2040.0%0.00%
Q4 2013$1,321,000
-27.2%
562,204
-28.1%
0.00%
Q3 2013$1,815,000
-38.7%
782,383
-38.5%
0.00%
Q2 2013$2,962,0001,271,3220.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Morgenthaler Management Partners IX, LLC 1,783,948$17,304,00018.83%
FRAZIER MANAGEMENT LLC 2,918,291$28,307,00011.84%
Avoro Capital Advisors LLC 3,515,611$34,101,00011.75%
Perceptive Advisors 15,239,444$147,823,00010.94%
Redmile Group, LLC 10,280,620$99,722,0007.46%
ACUTA CAPITAL PARTNERS, LLC 1,502,661$14,576,0006.97%
SECTORAL ASSET MANAGEMENT INC 7,973,436$77,342,0003.30%
Asymmetry Capital Management, L.P. 195,206$1,893,0002.86%
Convector Capital Management, LP 210,500$2,042,0001.92%
Palo Alto Investors LP 3,551,173$34,446,0001.92%
View complete list of AMICUS THERAPEUTICS INC shareholders